Silvant Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.02M | Hold |
4,037
| – | – | 0.03% | 165 |
|
|
2026
Q1 | $878K | Hold |
4,037
| – | – | 0.03% | 157 |
|
|
2025
Q4 | $922K | Hold |
4,037
| – | – | 0.03% | 153 |
|
|
2025
Q3 | $935K | Hold |
4,037
| – | – | 0.03% | 152 |
|
|
2025
Q2 | $749K | Hold |
4,037
| – | – | 0.03% | 152 |
|
|
2025
Q1 | $846K | Hold |
4,037
| – | – | 0.04% | 150 |
|
|
2024
Q4 | $717K | Hold |
4,037
| – | – | 0.03% | 152 |
|
|
2024
Q3 | $797K | Hold |
4,037
| – | – | 0.04% | 149 |
|
|
2024
Q2 | $692K | Hold |
4,037
| – | – | 0.03% | 148 |
|
|
2024
Q1 | $735K | Hold |
4,037
| – | – | 0.04% | 155 |
|
|
2023
Q4 | $626K | Hold |
4,037
| – | – | 0.03% | 151 |
|
|
2023
Q3 | $602K | Hold |
4,037
| – | – | 0.04% | 154 |
|
|
2023
Q2 | $544K | Hold |
4,037
| – | – | 0.03% | 151 |
|
|
2023
Q1 | $643K | Hold |
4,037
| – | – | 0.04% | 142 |
|
|
2022
Q4 | $652K | Hold |
4,037
| – | – | 0.05% | 140 |
|
|
2022
Q3 | $542K | Hold |
4,037
| – | – | 0.04% | 147 |
|
|
2022
Q2 | $618K | Hold |
4,037
| – | – | 0.15% | 95 |
|
|
2022
Q1 | $654K | Sell |
4,037
-740
| -15% | -$107K | 0.12% | 107 |
|
|
2021
Q4 | $647K | Hold |
4,777
| – | – | 0.11% | 108 |
|
|
2021
Q3 | $515K | Hold |
4,777
| – | – | 0.09% | 117 |
|
|
2021
Q2 | $538K | Hold |
4,777
| – | – | 0.08% | 122 |
|
|
2021
Q1 | $517K | Hold |
4,777
| – | – | 0.09% | 126 |
|
|
2020
Q4 | $512K | Hold |
4,777
| – | – | 0.09% | 121 |
|
|
2020
Q3 | $418K | Hold |
4,777
| – | – | 0.08% | 123 |
|
|
2020
Q2 | $469K | Buy |
4,777
+226
| +5% | +$19.9K | 0.08% | 117 |
|
|
2020
Q1 | $347K | Hold |
4,551
| – | – | 0.08% | 118 |
|
|
2019
Q4 | $403K | Hold |
4,551
| – | – | 0.07% | 125 |
|
|
2019
Q3 | $345K | Sell |
4,551
-1,004
| -18% | -$68.8K | 0.07% | 128 |
|
|
2019
Q2 | $404K | Hold |
5,555
| – | – | 0.07% | 129 |
|
|
2019
Q1 | $448K | Hold |
5,555
| – | – | 0.08% | 124 |
|
|
2018
Q4 | $512K | Hold |
5,555
| – | – | 0.1% | 108 |
|
|
2018
Q3 | $525K | Hold |
5,555
| – | – | 0.06% | 120 |
|
|
2018
Q2 | $515K | Hold |
5,555
| – | – | 0.06% | 117 |
|
|
2018
Q1 | $526K | Buy |
+5,555
| New | +$610K | 0.07% | 112 |
|
Other funds holding ABBV
Silvant Capital Management's ABBV Position: Q2 2026 in Review
Silvant Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 4,037 shares worth $1.02M. The position accounts for 0.03% of the portfolio, ranked #165.
Silvant Capital Management first reported a position in ABBV in Q1 2018 and has held it in 34 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Silvant Capital Management held 4,037 shares of AbbVie worth $1.02M as of Q2 2026.
- Silvant Capital Management left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.03% of Silvant Capital Management's portfolio in Q2 2026, its #165 holding.
- Silvant Capital Management first reported a position in AbbVie in Q1 2018 and has held it in 34 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Silvant Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.